-1366x0.jpg)
As a supporting sponsor, GENTIS was honored to participate in the conference and received much attention and appreciation from the professional community. This was an opportunity for GENTIS to reaffirm its role in the fields of genetic analysis and precision medicine—key components in the modern healthcare ecosystem.
JCI – A Global Benchmark for Healthcare Quality
The theme “JCI & JCI Enterprise – The Symphony of Healthcare Operations” was not only a highlight of ACP 2025 but also a testament to Phuong Chau Healthcare Group’s journey in enhancing healthcare quality. JCI (Joint Commission International) is one of the world’s most rigorous standards for healthcare quality and safety, with over 2,500 stringent criteria, including patient safety, infection control, medication management, emergency response, quality management, and safety for healthcare workers.
Phuong Chau Healthcare Group is proud to be among the top 10 healthcare groups globally and the first in Southeast Asia to be accredited with JCI Enterprise. Additionally, 3 out of 4 hospitals in its network have achieved JCI accreditation: Phuong Chau Can Tho, Phuong Chau Soc Trang, and Phuong Nam. This milestone is not only a source of pride for Phuong Chau but also marks a significant step forward for Vietnam’s healthcare sector on the global stage.
ACP 2025 – Gathering Leading Domestic and International Experts
ACP 2025 brought together many of Vietnam’s top JCI-accredited hospitals, including Vinmec Central Park, FV Hospital, American International Hospital (AIH), Cao Thang Eye Hospital, and of course, the host—Phuong Chau Healthcare Group. The conference also featured international experts from The Medical City (Philippines)—a renowned ASEAN hospital with JCI accreditation—alongside leading specialists in Obstetrics, Gynecology, and Neonatology.
The conference was structured into 10 thematic sessions, with 36 in-depth presentations covering key topics such as:
- High-quality operational models and holistic employee care
- Safety in treatment
- Safety in laboratory and diagnostic services
- Safety in IT and healthcare infrastructure
- In-depth updates and notable clinical cases in Obstetrics, Gynecology, and Neonatology
The diversity and depth of the sessions reflect the medical community’s ongoing commitment to advancing knowledge, improving clinical practice, and adopting modern healthcare management models.
GENTIS – A Pioneer in Genetic Analysis, Partnering with Modern Medicine
As a pioneering institution in genetic testing and precision medicine, GENTIS brought groundbreaking solutions to ACP 2025 that support screening, diagnosis, and personalized treatment. The GENTIS booth at the event attracted special interest from hundreds of delegates and experts. Here, GENTIS showcased cutting-edge technologies already widely applied in leading IVF centers and hospitals:
- PGT Next: Detects aneuploidy/monosomy in embryos – enhancing success rates in assisted reproduction.
- PGT Upgrade: Identifies embryos carrying balanced translocations – reducing inherited disease risks.
- PGT-M for 100+ rare diseases: Screens for over 100 monogenic diseases – helping carrier couples select healthy embryos.
- PGT MAX 1: High-resolution genetic screening – increasing screening accuracy.
- Thrombophilia: Screens for gene mutations associated with clotting disorders – particularly important during pregnancy.
- Thalassemia: Screens for inherited anemia – minimizing the risk of having a child with thalassemia.
- Genratest: Determines the optimal implantation window – maximizing IVF treatment success.
Through these innovative products and services, GENTIS continues to bridge the gap between scientific research and practical application, contributing significantly to improving treatment outcomes and quality of life.
Commitment to a Sustainable Healthcare Mission
ACP 2025 stands as a clear testament to the effective collaboration between healthcare organizations, experts, scientists, and businesses. GENTIS is proud to accompany the conference in its mission to spread knowledge, foster professional connections, and build a healthcare system that is high-quality, safe, and patient-centered.
Looking ahead, GENTIS hopes to continue its partnership with ACP and both domestic and international partners to fulfill its mission: “Enhancing the intellect and physical well-being of Vietnamese people” through advanced, accurate, and personalized genetic testing solutions.
